ACTEMRA
Live / Registered — Registered and renewed (as of 25 Sept 2025)
What this means for you
Registered since 16 Aug 2005. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Aug 2025).
Record
- Serial number
- 78227672
- Registration number
- 2984926
- Mark type
- Word mark
- Filed
- 19 Mar 2003
- Published for opposition
- 24 May 2005
- Registered
- 16 Aug 2005
- Next maintenance due
- 16 Aug 2025
- Attorney of record
- Mainak H. Mehta
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS, NAMELY, ANTI-INTERLEUKIN-6 (IL-6) RECEPTOR MONOCLONAL ANTIBODY FOR THE TREATMENT OF DISEASE CAUSED BY IL-6 PRODUCTION
Owner
- CHUGAI SEIYAKU KABUSHIKI KAISHA, TOKYO, JP
- CHUGAI SEIYAKU KABUSHIKI KAISHA, TOKYO, JP
- CHUGAI SEIYAKU KABUSHIKI KAISHA, TOKYO, JP
Prosecution history
- 25 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 25 Sept 2025 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 25 Sept 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 25 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jun 2025 — TEAS SECTION 8 & 9 RECEIVED
- 16 Aug 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Jul 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 05 Jun 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Sept 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 24 Sept 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 24 Sept 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 24 Sept 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Sept 2014 — TEAS SECTION 8 & 9 RECEIVED
- 27 Feb 2011 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Feb 2011 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL